This ONLY Happens RIGHT Before a Recession—And the Fed JUST Did It!

Key Concepts

• Federal Reserve Rate Cut: A reduction in the target federal funds rate by the Federal Reserve, intended to stimulate the economy.
• Quantitative Tightening (QT): The process by which the Federal Reserve reduces the size of its balance sheet by allowing assets to mature without reinvesting the proceeds.
• Repo Markets: Markets where financial institutions lend and borrow securities and cash on a short-term basis, often overnight.
• Dollar Shortage: A situation where there is insufficient supply of US dollars in the global financial system.
• Subprime Cracks: Signs of stress and potential defaults in the subprime mortgage market or other lower-quality debt segments.
• Balance Sheet (Fed's): The total assets and liabilities of the Federal Reserve.
• Quantitative Easing (QE): The process by which the Federal Reserve increases the size of its balance sheet by purchasing assets, injecting liquidity into the economy.
• Asset Swap: A transaction where one asset is exchanged for another. In the context of QE, it refers to the Fed exchanging reserves for securities.
• Reserves (Bank): Funds that commercial banks hold at the Federal Reserve.
• SOFR (Secured Overnight Financing Rate): A benchmark interest rate for dollar-denominated overnight risk-free collateralized loans.
• Fed Lending Facility: A facility provided by the Federal Reserve to banks to borrow money, often as a backstop.
• Liquidity: The availability of cash or easily convertible assets in the financial system.
• Credit Freeze: A situation where lending activity significantly slows down or stops due to a lack of confidence or available funds.
• Elliot Wave Theory: A technical analysis tool that attempts to predict market movements by identifying recurring patterns in price charts.
• Volume Profile: A trading indicator that displays trading volume at different price levels over a specific period.
• FDA Fast Track Designation: A process by the Food and Drug Administration (FDA) to expedite the development and review of drugs for serious conditions.
• PoloRep: An investigational cancer therapy developed by Encelics Biotech.

Federal Reserve Actions and Market Reactions

The Federal Reserve announced a quarter-point rate cut, lowering the federal funds rate target to 3.75-4%. This was the second cut in the cycle. Simultaneously, the Fed announced that Quantitative Tightening (QT) would conclude on December 1st. While the market initially cheered the rate cut, expecting a bull run fueled by increased liquidity, the opposite occurred. Stocks and gold began to sell off. This reaction suggests that the Fed's actions are being interpreted not as a proactive measure to prevent a recession, but as a "desperate signal of doom" in the face of mounting economic stress.

Underlying Economic Stressors

The video highlights several critical indicators pointing to a brewing crisis:

• Repo Markets Flashing Red: This indicates stress in the short-term lending market, where financial institutions borrow and lend cash against collateral. When repo providers become nervous and reduce lending, it signifies a drying up of liquidity.
• Brewing Dollar Shortage: A global shortage of US dollars is exacerbating economic slowdowns. Dollars are essential for servicing existing debt, and a lack of them leads to rising delinquencies, defaults, and cracks in the subprime market.
• Widening Subprime Cracks: Stress is building in the subprime space, a direct consequence of liquidity drying up and credit freezing. This leads to businesses cutting back on hiring or initiating layoffs.

The Fed's Balance Sheet and Quantitative Easing (QE)

The video explains that the Fed's balance sheet expansion during crises (2007-2009 and the pandemic) was aimed at stabilizing markets and stimulating the economy. However, it clarifies that Quantitative Easing (QE) is not "money printing" but rather an "asset swap." When the Fed buys securities, it creates reserves (electronic cash) for banks. When these securities mature, this electronic money drains from the financial system. Crucially, these reserves cannot leave the banking system, meaning it's not direct money printing.

The unwinding of the Fed's balance sheet (QT) since 2022, which has reduced it to approximately $6.6 trillion, has been a concern for officials. They need to maintain control over short-term interest rates, as a jump in these rates signals financial system stress and can impact mortgage rates, business lending, and credit flow.

Signs of Liquidity Drying Up

Several signs point to reserves and broader cash becoming less ample:

• Banks Borrowing at the Upper End of the Federal Funds Rate: This indicates that banks with excess cash are hesitant to lend to those that are short.
• SOFR Rates Moving Higher: Similar to the above, this suggests increased cost and difficulty in obtaining overnight funding.
• Repo Providers Getting Nervous: As mentioned, this is a direct indicator of reduced liquidity in the overnight lending market.
• Banks Tapping Fed Lending Facilities: Banks are increasingly relying on the Fed's lending facilities because they cannot secure cash from traditional repo providers, signaling a shortage of readily available funds.

The video emphasizes that the repo market is essentially where individuals with securities can get an overnight loan for cash when they can't obtain it from the financial system.

Gold's Performance and Historical Context

While many are bullish on gold long-term, its current sell-off after the Fed rate cut is explained by historical patterns. Typically, gold corrects lower after the Federal Reserve begins cutting interest rates before resuming its rally, usually 10-12 weeks later on average. The video shows a chart illustrating that gold rallies after the first rate cut, then sells off before its next rally. The current price action aligns with this historical pattern. The potential downside for gold is estimated to be around $38.40, with a worst-case scenario of $3,100 based on fair value models against the liquidity squeeze. The current weakness is seen as a way to "shake out the weak hands" after a significant rally.

Stock Market Outlook and Historical Parallels

Contrary to the belief that rate cuts are bullish for stocks, the video presents a chart of the federal funds rate versus the NASDAQ 100, drawing parallels to past crises:

• Dot-Com Bubble: The market rallied, pulled back, and then rallied again. As the Fed aggressively cut rates, the labor market deteriorated, and the stock market fell.
• Financial Crisis: Similar to the dot-com bubble, the market initially reacted positively to Fed cuts before realizing the Fed was in panic mode, leading to a market collapse.
• Pandemic: In contrast, rate cuts during the pandemic were perceived as bullish, and stocks continued to rise.

The current situation is presented as a critical juncture, questioning whether stocks will be immune to downside risk this time. The Fed's actions are seen as injecting short-term "juice" into the system to address the repo problem and encourage lending, with the goal of preventing stock market declines.

Recession Odds and Future Projections

Goldman Sachs estimates recession odds at 30% or more for the next year. However, if holiday spending disappoints and businesses begin to shut down or lay off workers, these odds are projected to skyrocket in the first quarter of next year. The lack of current economic data means the Fed is "flying blind." If the upcoming data is poor, another rate cut in December is anticipated.

Actionable Advice for Investors

Given the projected economic downturn and potential for further Fed cuts, the following actions are recommended:

• Lock in Savings Yields: Secure current high yields on savings before the Fed continues to cut rates.
• Take Profits on High-Flying Tech Stocks: Reduce exposure to speculative tech stocks.
• Invest in Defensive Assets: Shift towards assets that are less sensitive to economic downturns.
• Hedge Gold Positions: For long-term gold holders, consider hedging to protect against potential pullbacks. Traders are advised to sell and re-enter on dips.
• Add Dollars and Treasuries: Increase holdings of US dollars and US Treasury securities, which are considered safe-haven assets.

These strategies are aimed at helping investors "thrive, not just survive" the coming crisis.

Encelics Biotech (NCY) - Investment Opportunity

The video also features Encelics Biotech (NASDAQ: NCY) as a potential investment opportunity.

• PoloRep Therapy: Encelics is developing PoloRep, an IV-delivered cancer therapy designed to make cancer cells visible to the immune system. It aims to target hard-to-treat tumors, including pancreatic and gastrointestinal cancers.
• Mechanism of Action: PoloRep multiplies inside tumors, causing them to burst while sparing healthy cells. It also converts "cold" tumors into "hot" ones, triggering immune responses.
• Clinical Progress: PoloRep has received FDA Fast Track Designation for pancreatic and breast cancer. The Goblet study in pancreatic cancer has shown promising response rates (e.g., 30% response rate in 20 patients in cohort 5, with median responses lasting about 15.5 months).
• Market Potential: The company is positioned to address the significant GI tumor market and can potentially be paired with other therapies.
• Elliot Wave Analysis: For Elliot Wave traders, the stock is noted to be holding its six-month volume profile at the beginning of a potential Wave 5 move, suggesting a possible breakout above $151 per share.

Disclaimer: Investors are advised to conduct their own research and use risk control levels when trading.

Conclusion

The Federal Reserve's recent rate cut and the announcement to end QT are interpreted not as a sign of economic strength, but as a response to significant underlying financial stress, including repo market tremors, a dollar shortage, and widening subprime cracks. These factors suggest a high probability of a recession. Historical patterns indicate that gold and stocks may experience further declines before a potential recovery. Investors are advised to adopt defensive strategies, lock in yields, and consider hedging their positions. Encelics Biotech is presented as a company with innovative cancer therapies and potential for significant growth.